Results 251 to 260 of about 46,843 (269)
Some of the next articles are maybe not open access.
Itraconazole in Human Histoplasmosis: Itraconazol bei Histoplasmose des Menschen
Mycoses, 1989Summary:A non‐comparative open trial with itraconazole in progressive forms of human histoplasmosis was carried out. Thirty two patients who completed 6 months of treatment were included; 29 suffered the chronic disseminated form; 2 exhibited a chronic pulmonary histoplasmosis and one patient presented a subacute disseminated form. Thirty patients were
A. M. Robles +3 more
openaire +2 more sources
Experience with itraconazole in cryptococcosis and aspergillosis
Journal of Infection, 1989Cryptococcosis and aspergillosis in immunocompromised patients are extremely difficult clinical conditions to manage and treatment with available antifungal drugs often fails. Itraconazole, R-51211, Janssen Pharmaceutica, a new orally absorbed triazole, is a possible alternative drug which is potentially effective and nontoxic.
Anna Maria Tortorano +14 more
openaire +3 more sources
Effect of omeprazole on the pharmacokinetics of itraconazole
European Journal of Clinical Pharmacology, 1998To investigate the effect of omeprazole on the pharmacokinetics of itraconazole.Eleven healthy volunteers received a single dose of oral itraconazole (200 mg) on days 1 and 15 and oral omeprazole (40 mg) once daily from day 2 to day 15. Itraconazole pharmacokinetics were studied on days 1 and 15.Concentrations of itraconazole were higher when it was ...
Somchai Sriwiriyajan +1 more
openaire +2 more sources
The many lives of itraconazole
Expert Opinion on Therapeutic Patents, 2003Since the discovery of the highly potent antifungal itraconazole (Sporanox®, Janssen Pharmaceutica) in the late 1970s, numerous patent applications and issued patents have appeared that describe and claim improvements for methods, manufacturing processes, formulations, enantiomers and uses for this commercially successful antifungal agent.
openaire +2 more sources
“Hedgehog pathway”: a potential target of itraconazole in the treatment of cancer
Journal of Cancer Research and Clinical Oncology, 2020Xin Wei, Wu Liu, Jia Qi Wang, Zeyao Tang
semanticscholar +1 more source
Itraconazole-Digoxin Interaction
Annals of Internal Medicine, 1992Excerpt To the Editors: Itraconazole, a triazole derivative of ketoconazole, has shown substantial promise as therapy for fungal infections (1).
openaire +2 more sources
Desensitization to itraconazole
Journal of Allergy and Clinical Immunology, 1997Robyn E O'Hehir +3 more
openaire +2 more sources
ITRACONAZOLE AND CYCLOSPORIN NEPHROTOXICITY
The Lancet, 1987Gerdy Veltman +5 more
openaire +3 more sources